Dr. El Shahawy advises clinicians to probe about all types of tobacco and nicotine use
“Goal setting for the patient is important,” says Omar El Shahawy, MD, MPH, PhD.
In this video, Omar El Shahawy, MD, MPH, PhD, discusses how clinicians can promote more transparency with their patients in terms of smoking status. El Shahawy is an assistant professor in the department of population health and co-director of the Global Health Selective at the New York University Grossman School of Medicine, and affiliated faculty in the division of global health at the New York University School of Global Public Health in New York City, New York.
Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer
February 7th 2022To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.
How appropriate use criteria for PSMA-PET imaging optimize patient care
February 2nd 2022In a recent interview, Hossein Jadvar, MD, PhD, discussed what the appropriate use criteria consist of for prostate-specific membrane antigen (PSMA)-PET imaging, and why these criteria are vital in ensuring the individualized care of patients.
Dr. Padmanabhan discusses impact of COVID-19
June 11th 2020Urology Times® Editorial Council Member Priya Padmanabhan, MD, MPH, professor of urology at Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, discusses how she has been affected by the coronavirus disease 2019 (COVID-19) pandemic.
